Nicholas Mitsiades
机构: Chief Translational Officer, Comprehensive Cancer Center, UC Davis Health
每年引用次数
引用次数
引用: 29,758
H-指数: 82
I10-指数 : 159
出版物: 402
Mutational and Immunohistochemical Study of the PI3K/Akt Pathway in Papillary Thyroid Carcinoma in Greece
Elias Sozopoulos , Helen Litsiou , Gerassimos Voutsinas , Nikolaos Mitsiades
Endocrine Pathology 21 ( 2) 90 -100
13
2010
TIMP3 Inhibits Vascular Leakage and Leukostasis in an Animal Model of Streptozotocin-Induced Diabetes
C. S. Mitsiades , E. Iliaki , J. W. Miller , V. Poulaki
Investigative Ophthalmology & Visual Science 48 ( 13) 1383 -1383
1
2007
Anti–FasL Neutralizing Antibody Increases the Efficacy of PDT and Reduces the Apoptotic Damage in a Rat Laser Model
C. Mitsiades , E. Iliaki , J.W. Miller , V. Poulaki
Investigative Ophthalmology & Visual Science 46 ( 13) 185 -185
1
2005
The Antidiabetic Biguanide Metformin Induces Growth Arrest in Retinoblastoma Cells in vitro
C. S. Mitsiades , J. W. Miller , M. Ooi , V. Poulaki
Investigative Ophthalmology & Visual Science 50 ( 13) 1699 -1699
2009
Antitumor Effects of the Histone Deacetylase Inhibitor Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Human Retinoblastoma Cell Lines: Therapeutic Implications
C. S. Mitsiades , J. Negri , V. Kotoula , J. W. Miller
Investigative Ophthalmology & Visual Science 49 ( 13) 26 -26
2008
The Proteasome Inhibitor Bortezomib (Velcade, PS–341) Induces Apoptosis in Human Retinoblastoma Cells: Therapeutic Implications
C.S. Mitsiades , J. Negri , V. Kotoula , J.W. Miller
Investigative Ophthalmology & Visual Science 47 ( 13) 2810 -2810
2006
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Induces Growth Arrest and Apoptosis in Human Retinoblastoma Cell Lines
C.S. Mitsiades , E. Iliaki , V. Poulaki , N. Mitsiades
Investigative Ophthalmology & Visual Science 44 ( 13) 931 -931
2003
Geldanamycin treatment reduces the inflammatory changes in the LPS–induced uveitis rat model
C.S. Mitsiades , D. Bula , E. Iliaki , J.W. Miller
Investigative Ophthalmology & Visual Science 45 ( 13) 3444 -3444
2004
Inhibition of Very Late Antigen–4 (VLA–4) Prevents Endotoxin–Induced Uveitis
D.V. Bula , E. Iliaki , J.W. Miller , A. Hafezi–Moghadam
Investigative Ophthalmology & Visual Science 45 ( 13) 575 -575
2004
Intensive insulin therapy–induced vascular leakage and leukostasis in diabetes are decreased by anti–IGF
N. Kociok , S. Dell , V. Poulaki , V. Poulaki
Investigative Ophthalmology & Visual Science 45 ( 13) 4111 -4111
1
2004
Aspirin and COX–2 inhibition reduce diabetic endothelial cell death via a Fas–FasL dependent mechanism.
N. Kociok , S. Fauser , V. Poulaki , N. Mitsiades
Investigative Ophthalmology & Visual Science 45 ( 13) 1095 -1095
2004
Geldanamycin Treatment Reduces Choroidal Neovascularization In A Murine Model
C.S. Mitsiades , E. Iliaki , J.W. Miller , V. Poulaki
Investigative Ophthalmology & Visual Science 47 ( 13) 371 -371
2006
Serum Adiponectin Concentrations and Tissue Expression of Adiponectin Receptors Are Reduced in Patients with Prostate Cancer: A Case Control Study
K. Michalakis , C. J. Williams , N. Mitsiades , J. Blakeman
Cancer Epidemiology, Biomarkers & Prevention 16 ( 2) 308 -313
154
2007
Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors.
C. J Williams , N. Mitsiades , E. Sozopoulos , A. Hsi
Endocrine-related Cancer 15 ( 1) 289 -299
72
2008
Increased expression of androgen receptor (AR) and enzymes involved in androgen synthesis in metastatic prostate cancer: Targets for novel personalized therapies
N. Mitsiades , N. Schultz , B. S. Taylor , H. Hieronymus
Journal of Clinical Oncology 27 5002 -5002
6
2009
Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.
S. R. Bornstein , E. L. Webster , D. J. Torpy , S. J. Richman
Endocrinology 139 ( 4) 1546 -1555
95
1998
A gene expression signature associated with sensitivity to the multikinase inhibitor dasatinib: Implications for development of a noninvasive biomarker for personalized therapy based on circulating tumor cell analysis.
N. Mitsiades , Y. Antipin , B. Reva , N. Schultz
Journal of Clinical Oncology 28 ( 15_suppl) 4544 -4544
1
2010
1 MOLECULAR PREDICTORS OF CLINICAL RESPONSE TO THE PROTEASOME INHIBITOR BORTEZOMIB: CLINICAL IMPLICATIONS FOR INDIVIDUALIZED PATIENT-SPECIFIC ANTI-CANCER THERAPEUTIC ALGORITHMS
C. S. Mitsiades , N. Mitsiades , P. G. Richardson , K. C. Anderson
Journal of Investigative Medicine 53 ( 2)
2005
Fas-mediated apoptosis in Ewing's sarcoma cell lines by metalloproteinase inhibitors.
N. Mitsiades , V. Poulaki , A. Leone , M. Tsokos
Journal of the National Cancer Institute 91 ( 19) 1678 -1684
48
1999
Glucocorticoids mediate adverse events of deep androgen receptor axis inhibition in prostate cancer patients.
S. Kaochar , N. Mitsiades
Annals of Oncology 31 ( 3) 323 -325
2
2020